Silanediols as Serine and Threonine Protease Inhibitors

硅烷二醇作为丝氨酸和苏氨酸蛋白酶抑制剂

基本信息

  • 批准号:
    7489356
  • 负责人:
  • 金额:
    $ 25.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-01 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Silanediols are recently developed analogues of the hydrated carbonyl that are effective as building blocks for low nanomolar inhibitors of metallo- and aspartic proteases. Serine proteases are also critical proteolytic enzymes whose inhibitors have broad therapeutic potential. The observation that Silanediols undergo facile, uncatalyzed exchange with methanol (initially observed with our HIV protease inhibitor) indicates that they have great potential as serine protease inhibitors as well. We will evaluate silandiols as inhibitors of serine and threonine proteases, studying five enzymes. Chymotrypsin is a benchmark and readily available serine protease that will allow us to rapidly establish Silanediols as serine protease inhibitors, including X-ray crystallography. Chymase is an important part of the immune response; the current understanding of the recognition sequence will allow us to quickly develop inhibitors. Cathepsin G is an enzyme involved in tissue remodeling with an overlap in specificity with chymase that will allow us to assess silanediol specificity. Granzyme B has a unique PI recognition requirement and is important in apoptosis. The 20S proteasome, a threonine protease, will test the limits of the Silanediols to interact with this important but sterically more hindered nucleophile. All targets except chymotrypsin are medically relevant, and silanediol inhibition will be further explored with enzyme X-ray crystallography (in collaboration with K. R. Acharya, Univ. of Bath)
描述(由申请人提供):硅二醇是最近开发的水合羰基类似物,可作为金属和天冬氨酸蛋白酶的低纳摩尔抑制剂的有效构建块。丝氨酸蛋白酶也是关键的蛋白水解酶,其抑制剂具有广泛的治疗潜力。观察到硅二醇与甲醇进行了容易的、非催化的交换(最初用我们的HIV蛋白酶抑制剂观察到),表明它们也具有作为丝氨酸蛋白酶抑制剂的巨大潜力。我们将评估硅烷二醇作为丝氨酸和苏氨酸蛋白酶的抑制剂,研究五种酶。凝乳胰蛋白酶是一种基准和现成的丝氨酸蛋白酶,将使我们能够快速建立硅二醇作为丝氨酸蛋白酶抑制剂,包括x射线晶体学。乳糜酶是免疫反应的重要组成部分;目前对识别序列的理解将使我们能够快速开发抑制剂。组织蛋白酶G是一种参与组织重塑的酶,在特异性上与乳糜酶重叠,这将使我们能够评估硅二醇的特异性。颗粒酶B具有独特的PI识别要求,在细胞凋亡中起重要作用。20S蛋白酶体,一种苏氨酸蛋白酶,将测试硅二醇与这种重要但在空间上更受阻的亲核试剂相互作用的极限。除了凝乳胰蛋白酶外,所有靶点都与医学相关,硅烷二醇抑制作用将通过酶x射线晶体学进一步探索(与巴斯大学的K. R. Acharya合作)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott McNeill Sieburth其他文献

Scott McNeill Sieburth的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott McNeill Sieburth', 18)}}的其他基金

Silanediols as Serine and Threonine Protease Inhibitors
硅烷二醇作为丝氨酸和苏氨酸蛋白酶抑制剂
  • 批准号:
    7282563
  • 财政年份:
    2006
  • 资助金额:
    $ 25.46万
  • 项目类别:
Silanediols as Serine and Threonine Protease Inhibitors
硅烷二醇作为丝氨酸和苏氨酸蛋白酶抑制剂
  • 批准号:
    7148986
  • 财政年份:
    2006
  • 资助金额:
    $ 25.46万
  • 项目类别:
Silanediols as Serine and Threonine Protease Inhibitors
硅烷二醇作为丝氨酸和苏氨酸蛋白酶抑制剂
  • 批准号:
    7689278
  • 财政年份:
    2006
  • 资助金额:
    $ 25.46万
  • 项目类别:
Anthrax LF Inhibitor Drug Based On Organosilanes
基于有机硅烷的炭疽 LF 抑制剂药物
  • 批准号:
    6561946
  • 财政年份:
    2002
  • 资助金额:
    $ 25.46万
  • 项目类别:
Anthrax LF Inhibitor Drug Based On Organosilanes
基于有机硅烷的炭疽 LF 抑制剂药物
  • 批准号:
    6652069
  • 财政年份:
    2002
  • 资助金额:
    $ 25.46万
  • 项目类别:
SILANOL INHIBITORS OF METALLOPROTEASE ENZYMES
金属蛋白酶的硅烷醇抑制剂
  • 批准号:
    2830696
  • 财政年份:
    1999
  • 资助金额:
    $ 25.46万
  • 项目类别:
SILANOL INHIBITORS OF METALLOPROTEASE ENZYMES
金属蛋白酶的硅烷醇抑制剂
  • 批准号:
    6184641
  • 财政年份:
    1999
  • 资助金额:
    $ 25.46万
  • 项目类别:
SILANOL INHIBITORS OF METALLOPROTEASE ENZYMES
金属蛋白酶的硅烷醇抑制剂
  • 批准号:
    6390302
  • 财政年份:
    1999
  • 资助金额:
    $ 25.46万
  • 项目类别:
INTRAMOLECULAR PYRONE/PYRIDONE (4+4) PHOTOCYCLOADDITIONS
分子内吡喃酮/吡啶酮 (4 4) 光环负载添加剂
  • 批准号:
    3304596
  • 财政年份:
    1991
  • 资助金额:
    $ 25.46万
  • 项目类别:
INTRAMOLECULAR PYRONE/PYRIDONE (4+4) PHOTOCYCLOADDITIONS
分子内吡喃酮/吡啶酮 (4 4) 光环负载添加剂
  • 批准号:
    3304597
  • 财政年份:
    1991
  • 资助金额:
    $ 25.46万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了